BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 20448835)

  • 1. Antiproteases as therapeutics to target inflammation in cystic fibrosis.
    Quinn DJ; Weldon S; Taggart CC
    Open Respir Med J; 2010 Mar; 4():20-31. PubMed ID: 20448835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteases and antiproteases in cystic fibrosis: pathogenetic considerations and therapeutic strategies.
    Birrer P
    Respiration; 1995; 62 Suppl 1():25-8. PubMed ID: 7792437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1 Antitrypsin-A Target for MicroRNA-Based Therapeutic Development for Cystic Fibrosis.
    Hunt AMD; Glasgow AMA; Humphreys H; Greene CM
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung.
    Twigg MS; Brockbank S; Lowry P; FitzGerald SP; Taggart C; Weldon S
    Mediators Inflamm; 2015; 2015():293053. PubMed ID: 26185359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation.
    Khan MA; Ali ZS; Sweezey N; Grasemann H; Palaniyar N
    Genes (Basel); 2019 Feb; 10(3):. PubMed ID: 30813645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airway epithelial cell inflammatory signalling in cystic fibrosis.
    Jacquot J; Tabary O; Le Rouzic P; Clement A
    Int J Biochem Cell Biol; 2008; 40(9):1703-15. PubMed ID: 18434235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease.
    Briottet M; Shum M; Urbach V
    Front Pharmacol; 2020; 11():1290. PubMed ID: 32982730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy.
    Cantin AM; Hartl D; Konstan MW; Chmiel JF
    J Cyst Fibros; 2015 Jul; 14(4):419-30. PubMed ID: 25814049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of CFTR function in macrophages alters the cell transcriptional program and delays lung resolution of inflammation.
    Wellems D; Hu Y; Jennings S; Wang G
    Front Immunol; 2023; 14():1242381. PubMed ID: 38035088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of
    Bernut A; Loynes CA; Floto RA; Renshaw SA
    Front Immunol; 2020; 11():1733. PubMed ID: 32849617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis.
    Cabrini G; Rimessi A; Borgatti M; Lampronti I; Finotti A; Pinton P; Gambari R
    Front Immunol; 2020; 11():1438. PubMed ID: 32849500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated Calcium Homeostasis in Cystic Fibrosis Neutrophils Leads to Deficient Antimicrobial Responses.
    Robledo-Avila FH; Ruiz-Rosado JD; Brockman KL; Kopp BT; Amer AO; McCoy K; Bakaletz LO; Partida-Sanchez S
    J Immunol; 2018 Oct; 201(7):2016-2027. PubMed ID: 30120123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches.
    Ghigo A; Prono G; Riccardi E; De Rose V
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NETs and CF Lung Disease: Current Status and Future Prospects.
    Gray RD; McCullagh BN; McCray PB
    Antibiotics (Basel); 2015 Jan; 4(1):62-75. PubMed ID: 27025615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications.
    Cohen-Cymberknoh M; Kerem E; Ferkol T; Elizur A
    Thorax; 2013 Dec; 68(12):1157-62. PubMed ID: 23704228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid CFTR loss-of-function causes persistent neutrophilic inflammation in cystic fibrosis.
    Ng HP; Jennings S; Wellems D; Sun F; Xu J; Nauseef WM; Wang G
    J Leukoc Biol; 2020 Dec; 108(6):1777-1785. PubMed ID: 32531843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation in cystic fibrosis: An update.
    Roesch EA; Nichols DP; Chmiel JF
    Pediatr Pulmonol; 2018 Nov; 53(S3):S30-S50. PubMed ID: 29999593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evidence-based treatment of cystic fibrosis].
    Ringshausen FC; Hellmuth T; Dittrich AM
    Internist (Berl); 2020 Dec; 61(12):1212-1229. PubMed ID: 33201261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.